Paradigm Biocapital Advisors’s Immunocore IMCR Stock Holding History

Paradigm Biocapital Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$116M	Buy
2023 Q4	$99.3M	Buy
2023 Q3	$71.9M	Buy
2023 Q2	$76.2M	Buy
2023 Q1	$55.7M	Buy
2022 Q4	$49M	Buy
2022 Q3	$36.3M	Buy
2022 Q2	$24.9M	Buy
2022 Q1	$14.9M	Buy
2021 Q4	$4.6M	Buy